.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Chubb
Dow
Fuji
Merck
Colorcon
Queensland Health
US Army
Julphar
Harvard Business School

Generated: November 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074543

« Back to Dashboard
NDA 074543 describes ALBUTEROL SULFATE, which is a drug marketed by Mova, Vintage, Copley Pharm, Pliva, Apotex Inc, Warner Chilcott, Teva, Ucb Inc, Roxane, Watson Labs, Actavis Mid Atlantic, Sun Pharm Inds, Ritedose Corp, Amneal Pharms, Hi Tech Pharma, Teva Pharms, Am Therap, Bausch And Lomb, Sandoz, Mylan Speclt, G And W Labs Inc, Nephron, Sun Pharma Global, Dava Pharms Inc, Landela Pharm, Watson Labs Inc, Vistapharm, Mylan, Wockhardt Eu Operatn, Cipla Ltd, Watson Labs Teva, and Sandoz Inc, and is included in sixty-five NDAs. It is available from thirty-three suppliers. Additional details are available on the ALBUTEROL SULFATE profile page.

The generic ingredient in ALBUTEROL SULFATE is albuterol sulfate; ipratropium bromide. There are thirty-seven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

Summary for 074543

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 074543

Mechanism of ActionAdrenergic beta2-Agonists

Suppliers and Packaging for NDA: 074543

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALBUTEROL SULFATE
albuterol sulfate
SOLUTION;INHALATION 074543 ANDA Rebel Distributors Corp. 21695-245 21695-245-20 1 BOTTLE, GLASS in 1 CARTON (21695-245-20) > 20 mL in 1 BOTTLE, GLASS
ALBUTEROL SULFATE
albuterol sulfate
SOLUTION;INHALATION 074543 ANDA A-S Medication Solutions 50090-0517 50090-0517-0 1 BOTTLE, GLASS in 1 CARTON (50090-0517-0) > 20 mL in 1 BOTTLE, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INHALATIONStrengthEQ 0.5% BASE
Approval Date:Jan 15, 1998TE:ANRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Citi
Cerilliant
US Army
McKinsey
Deloitte
Johnson and Johnson
Harvard Business School
Dow
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot